Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be ...

Around 6,600 people are diagnosed with stomach cancer every year in Britain. Despite the disease not being one of the most ...

A new study projects that millions of stomach cancer cases globally could be fueled by the Helicobacter pylori bacteria.

Hundreds of people with persistent heartburn or acid reflux will be offered a “sponge on a string” test in high-street pharmacies for the first time. NHS England is piloting a new way of preventing ...

As many as 15.6 million people born between 2008 and 2017 globally are expected to develop gastric cancer sometime in their ...

A paper in the British Journal of Surgery indicates that early-onset gastrointestinal cancer rates are rising dramatically ...

A new paper in BJS, published by Oxford University Press, indicates that early-onset gastrointestinal cancer rates are rising ...

Arturo Loaiza-Bonilla, MD, MSEd, systemwide chief of hematology and oncology at St. Lukes University Health Network and ...

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

Treatment for stomach cancer often involves a combination of surgery, chemotherapy, targeted therapy, immunotherapy, radiation, and palliative care. Read on.

Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...